You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Exercise Disclosure
King-jones Heidy · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
King-jones Heidy See Remarks
SYRE
Spyre Therapeutics
SYRE
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
SYRE daily price context
Close on/before transaction
$87.05
Sep 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 400 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001636282-26-000111
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$2.89M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE Current | Exercise | Sep 2, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE | Exercise | Sep 2, 2026 | $5.8K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 2, 2026 | $36K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $1.44M |
| Spyre Therapeutics, Inc. SYRE | Exercise | Sep 1, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $547.18K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Sep 1, 2026 | $405.99K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $35.75K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $418.61K |